000			02169 a2200577 4500
005			20250516083920.0
264		0	_c20120710
008			201207s 0 0 eng d
022			_a1524-4539
024	7		_a10.1161/CIRCULATIONAHA.111.081125 _2doi
040			_aNLM _beng _cNLM
100	1		_aLindman, Brian R
245	0	0	_aEffects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis. _h[electronic resource]
260			_bCirculation _cMay 2012
300			_a2353-62 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAortic Valve Stenosis _xdiagnostic imaging
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCompliance _xdrug effects
650	0	4	_aCyclic Nucleotide Phosphodiesterases, Type 5 _xmetabolism
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aPhosphodiesterase 5 Inhibitors _xadministration & dosage
650	0	4	_aPiperazines _xadministration & dosage
650	0	4	_aPulmonary Circulation _xdrug effects
650	0	4	_aPurines _xadministration & dosage
650	0	4	_aSeverity of Illness Index
650	0	4	_aSildenafil Citrate
650	0	4	_aStroke Volume _xdrug effects
650	0	4	_aSulfones _xadministration & dosage
650	0	4	_aTreatment Outcome
650	0	4	_aUltrasonography
650	0	4	_aVascular Resistance _xdrug effects
650	0	4	_aVentricular Function, Left _xdrug effects
650	0	4	_aVentricular Function, Right _xdrug effects
700	1		_aZajarias, Alan
700	1		_aMadrazo, José A
700	1		_aShah, Jay
700	1		_aGage, Brian F
700	1		_aNovak, Eric
700	1		_aJohnson, Stephanie N
700	1		_aChakinala, Murali M
700	1		_aHohn, Tara A
700	1		_aSaghir, Mohammed
700	1		_aMann, Douglas L
773	0		_tCirculation _gvol. 125 _gno. 19 _gp. 2353-62
856	4	0	_uhttps://doi.org/10.1161/CIRCULATIONAHA.111.081125 _zAvailable from publisher's website
999			_c21651334 _d21651334